Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-087735
Filing Date
2013-03-01
Accepted
2013-03-01 16:18:35
Documents
1
Group Members
JAMES NIEDELJEANI DELAGARDELLENEW LEAF VENTURE ASSOCIATES II, L.P.NEW LEAF VENTURE MANAGEMENT II, L.L.C.PHILIPPE O. CHAMBONRONALD HUNTSRINIVAS AKKARAJUVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D d494133dsc13da.htm SC 13D/A 184516
  Complete submission text file 0001193125-13-087735.txt   186463
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-79594 | Film No.: 13657866
SIC: 2834 Pharmaceutical Preparations

Mailing Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 (646) 871-6400
New Leaf Ventures II, L.P. (Filed by) CIK: 0001441439 (see all company filings)

EIN.: 320214549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A